Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]

Bibliographic Details
Main Authors:	Lanqing Cao, Shu Wang, Limei Zhang, Jiannan Li
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223000689

Retraction notice to “mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3” [Biomed. Pharmacother. 146 (2022) 112608]
by: Lanqing Cao, et al.
Published: (2023-04-01)

Corrigendum to “Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering” [Biomed. Pharmacother. 148 (2022) 112782]
by: Murad Alahdal, et al.
Published: (2022-09-01)

Corrigendum to “Tegaserod maleate exhibits antileukemic activity by targeting TRPM8” [Biomed. Pharmacother. 154 (2022) 113566]
by: Xiaoling Xie, et al.
Published: (2023-10-01)

Corrigendum to “Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice.” [Biomed. Pharmacother. 150 (2022) 112936]
by: Duoduo Zhang, et al.
Published: (2024-01-01)

Corrigendum to “Sacubitril/valsartan combination enhanced cardiac glycophagy and prevented the progression of murine diabetic cardiomyopathy” [Biomed. Pharmacother. 153 (2022) 113382]
by: Dina Salem Abdelaziz Elshenawy, et al.
Published: (2022-12-01)

Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01)

Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)

Corrigendum to: “Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death” [Biomed. Pharmacother. 153 (2022) 113511]
by: Li Liu, et al.
Published: (2023-12-01)

Corrigendum to “In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.)” [Biomed. Pharmacother. (2022) 112611]
by: Lenh Vo Van, et al.
Published: (2023-11-01)

Retraction Notice to “Pharmacological evaluation of continentalic acid for antidiabetic potential” [Biomed. Pharmacother. 138 (2021) 111411]
by: Iqra Liaquat, et al.
Published: (2024-01-01)

Corrigendum to “Steatosis in metabolic diseases: A focus on lipolysis and lipophagy” [Biomed. Pharmacother. 160 (2023) 114311]
by: Xingtao Zhao, et al.
Published: (2023-07-01)

Corrigendum to “Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies” [Biomed. Pharmacother. 150 (2022) 112949]
by: Li-ping Zhao, et al.
Published: (2023-08-01)

Corrigendum to: “Gegen Qinlian decoction ameliorates murine colitis by inhibiting the expansion of Enterobacteriaceae through activating PPAR-γ signaling” Biomed. Pharmacother. 154 (2022) 113571
by: Jingyi Hu, et al.
Published: (2023-01-01)

Corrigendum to ‘Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro’ Biomed. Pharmacother. 107 (2018) 738–745
by: Dan Li, et al.
Published: (2023-10-01)

Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]
by: Chang Shin Yoon, et al.
Published: (2023-12-01)

Retraction notice to “Salidroside alleviates cigarette smoke-induced COPD in mice” [Biomed. Pharmacother. 86 (2017) 155–161]
by: Fen Luo, et al.
Published: (2023-04-01)

Retraction notice to “ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells” [Biomed. Pharmacother. 70 (2015) 90–96]
by: Tao Yin, et al.
Published: (2023-04-01)

Corrigendum to “The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy” Biomed. Pharmacother. 165 (2023) 114893
by: Shuo Yuan, et al.
Published: (2024-02-01)

Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
by: Tang Ziyang, et al.
Published: (2023-12-01)

Erratum to alkaloids in commercial preparations of California poppy – Quantification, intestinal permeability and microbiota interactions [Biomed. Pharmacother. 166 (2023) 115420]
by: Antoine Chauveau, et al.
Published: (2023-11-01)

Corrigendum to “Paeonia lactiflora Pallas extract alleviates Antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice” [Biomed. Pharmacother. 154 (2022) 113574]
by: Seo Yeon Lee, et al.
Published: (2023-09-01)

Corrigendum to “Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells” [Biomed. Pharmacother. 149 (2022) 112804]
by: Antonio José Ruiz-Alcaraz, et al.
Published: (2022-08-01)

Corrigendum to “Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy” Biomed. Pharmacother. 171 (2024) 116152
by: Xiangyun You, et al.
Published: (2024-04-01)

Retraction notice to 'Potential role of andrographolide in the proliferation of osteoblasts mediated by the ERK signaling pathway' [Biomed. Pharmacother. 83 (2016) 1335–1344]
by: Bo Li, et al.
Published: (2023-07-01)

Corrigendum to “Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine” Biomed. Pharmacother. 170 (2024) 115952
by: Yu Chen, et al.
Published: (2024-01-01)

Retraction notice to “Effect of an aqueous extract of Averrhoa carambola L. on endothelial function in rats with ventricular remodelling” [Biomed. Pharmacother. 121 (2019) 109612]
by: Xingmei Liang, et al.
Published: (2024-04-01)

Editor’s Note on “Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate” [Biomed. Pharmacother. 171 (2024) 116055]
by: Danyelle Townsend
Published: (2024-02-01)

Corrigendum to “Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats” [Biomed. Pharmacother. 162 (2023) 114689]
by: Pengpeng Zhang, et al.
Published: (2023-08-01)

Corrigendum to “vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats” [Biomed. Pharmacother. 96 (2017) 667–674]
by: Seyed Esmaeil Khoshnam, et al.
Published: (2023-09-01)

Corrigendum to: “Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis”, [Biomed. Pharmacother., 161; (2023): 114472]
by: Liang Shan, et al.
Published: (2023-06-01)

Retraction notice to “Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic mice” [Biomed. Pharmacother. 84 (2016) 1820–1825]
by: Zhao-Chuan Yang, et al.
Published: (2024-02-01)

Retraction notice to “MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320]
by: Dacheng Wen, et al.
Published: (2023-11-01)

Retraction notice to “The effect of microRNA-328 antagomir on erectile dysfunction instreptozotocin-induced diabetic rats” [Biomed. Pharmacother. 92 (2017) 888–895]
by: Dong-Shui Li, et al.
Published: (2023-08-01)

Corrigendum to “Aloe vera gel improves behavioral deficits and oxidative status in streptozotocin-induced diabetic rats” [Biomed. Pharmacother. 96 (2017) 279–290]
by: Seyed Reza Fatemi Tabatabaei, et al.
Published: (2023-09-01)

Retraction notice to “POLD1 deficiency is involved in cognitive function impairment in AD patients and SAMP8 mice” [Biomed. Pharmacother. 114 (2019) 108833]
by: Shichao Gao, et al.
Published: (2023-04-01)

Corrigendum to “Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy” Biomed. Pharmacother. 169 (2023) 115881
by: Manni Rohilla, et al.
Published: (2024-01-01)

Retraction Notice to “Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats” [Biomed. Pharmacother. 142 (2021) 111666]
by: Nada H. Eisa, et al.
Published: (2024-01-01)

Corrigendum to “Protective effects of Punica granatum (pomegranate) peel extract on concanavalin A-induced autoimmune hepatitis in mice” [Biomed. Pharmacother. 100 (2018) 213–220]
by: Tingting Wang, et al.
Published: (2023-12-01)

Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491]
by: Pratibha Pandey, et al.
Published: (2023-11-01)

Corrigendum to “A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer” [Biomed. Pharmacother. 117 (2019) 109072]
by: Xin Li, et al.
Published: (2023-09-01)

Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]

Similar Items

Similar Items